Literature DB >> 9660992

Erythromycin inhibits tumor necrosis factor alpha and interleukin 6 production induced by heat-killed Streptococcus pneumoniae in whole blood.

M J Schultz1, P Speelman, S Zaat, S J van Deventer, T van der Poll.   

Abstract

To determine the effects of penicillin and erythromycin on cytokine production induced by heat-killed Streptococcus pneumoniae (HKSP), we studied the effects of those drugs on cytokine production induced by S. pneumoniae in human whole blood in vitro and ex vivo. In whole blood in vitro, erythromycin, but not penicillin, caused a dose-dependent decrease in HKSP-induced production of tumor necrosis factor alpha (TNF) and interleukin 6 (IL-6), while the production of IL-10, IL-12, and gamma interferon was inhibited only at the highest erythromycin concentration tested (10(-3) M). The production of TNF and IL-6 in whole blood obtained from healthy subjects after a 30-min infusion of erythromycin (1,000 mg) was lower after ex vivo stimulation with HKSP than that in blood drawn before the infusion. Inhibition of TNF contributed to erythromycin-induced inhibition of IL-6 synthesis. Inhibition of TNF and IL-6 production by erythromycin may have a negative impact on host defense mechanisms during pneumococcal pneumonia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9660992      PMCID: PMC105654     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  33 in total

1.  Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalization.

Authors:  A Ortqvist; J Hedlund; L Grillner; E Jalonen; I Kallings; M Leinonen; M Kalin
Journal:  Eur Respir J       Date:  1990-11       Impact factor: 16.671

2.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

3.  Differential regulation of IL 6, IL 1 A, IL 1 beta and TNF alpha production in LPS-stimulated human monocytes: role of cyclic AMP.

Authors:  S Bailly; B Ferrua; M Fay; M A Gougerot-Pocidalo
Journal:  Cytokine       Date:  1990-05       Impact factor: 3.861

4.  Monoclonal antibodies to human tumor necrosis factor alpha: in vitro and in vivo application.

Authors:  A Möller; F Emling; D Blohm; E Schlick; K Schollmeier
Journal:  Cytokine       Date:  1990-05       Impact factor: 3.861

5.  Epinephrine inhibits endotoxin-induced IL-1 beta production: roles of tumor necrosis factor-alpha and IL-10.

Authors:  T Van der Poll; S F Lowry
Journal:  Am J Physiol       Date:  1997-12

Review 6.  Pneumococcal resistance to antibiotics.

Authors:  K P Klugman
Journal:  Clin Microbiol Rev       Date:  1990-04       Impact factor: 26.132

7.  Effects of an immunosuppressant, FK506, on interleukin 1 alpha production by human macrophages and a macrophage-like cell line, U937.

Authors:  N Keicho; S Sawada; K Kitamura; H Yotsumoto; F Takaku
Journal:  Cell Immunol       Date:  1991-02       Impact factor: 4.868

8.  Erythromycin and roxithromycin potentiate human neutrophil locomotion in vitro by inhibition of leukoattractant-activated superoxide generation and autooxidation.

Authors:  R Anderson
Journal:  J Infect Dis       Date:  1989-05       Impact factor: 5.226

9.  Biphasic production of IL-8 in lipopolysaccharide (LPS)-stimulated human whole blood. Separation of LPS- and cytokine-stimulated components using anti-tumor necrosis factor and anti-IL-1 antibodies.

Authors:  L E DeForge; J S Kenney; M L Jones; J S Warren; D G Remick
Journal:  J Immunol       Date:  1992-04-01       Impact factor: 5.422

10.  Differential modulation of cytokine production by macrolides: interleukin-6 production is increased by spiramycin and erythromycin.

Authors:  S Bailly; J J Pocidalo; M Fay; M A Gougerot-Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

View more
  20 in total

Review 1.  The anti-inflammatory effects of macrolides.

Authors:  D Wales; M Woodhead
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

2.  Tailoring Antibiotic Treatment to Host Immune Status: The Host, Not the Drug, Determines Outcome.

Authors:  Peter J. McDonald; Hendrik Pruul
Journal:  Curr Infect Dis Rep       Date:  2001-08       Impact factor: 3.725

Review 3.  Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?

Authors:  M T Labro
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

4.  On-chip evaluation of neutrophil activation and neutrophil-endothelial cell interaction during neutrophil chemotaxis.

Authors:  Donghyuk Kim; Christy L Haynes
Journal:  Anal Chem       Date:  2013-10-28       Impact factor: 6.986

Review 5.  Immuno-modulation and anti-inflammatory benefits of antibiotics: the example of tilmicosin.

Authors:  André G Buret
Journal:  Can J Vet Res       Date:  2010-01       Impact factor: 1.310

6.  Erythromycin inhibits transcriptional activation of NF-kappaB, but not NFAT, through calcineurin-independent signaling in T cells.

Authors:  Y Aoki; P N Kao
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

Review 7.  Mechanisms of action and clinical application of macrolides as immunomodulatory medications.

Authors:  Soichiro Kanoh; Bruce K Rubin
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

Review 8.  Immunomodulatory effects of macrolide antibiotics in respiratory disease: therapeutic implications for asthma and cystic fibrosis.

Authors:  Sanjiv Sharma; Adam Jaffe; Garth Dixon
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

9.  The Nonantibiotic Macrolide EM703 Improves Survival in a Model of Quinolone-Treated Pseudomonas aeruginosa Airway Infection.

Authors:  Gopinath Kasetty; Ravi K V Bhongir; Praveen Papareddy; Heiko Herwald; Arne Egesten
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

10.  Modulation of polymorphonuclear cell interleukin-8 secretion by human monoclonal antibodies to type 8 pneumococcal capsular polysaccharide.

Authors:  Tamika Burns; Zhaojing Zhong; Michael Steinitz; Liise-anne Pirofski
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.